Annual Drug Patent Expirations for BYDUREON+BCISE
Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.
BYDUREON BCISE drug price trends.
Drug patent litigation for BYDUREON BCISE.
The generic ingredient in BYDUREON BCISE is exenatide synthetic. One supplier is listed for this compound. Additional details are available on the exenatide synthetic profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
